Publications

5674 Results

Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities

Authors
D Morgan;J Torres;R Sexton;R Herrero;E Salazar-Martinez;ER Greenberg;LE Bravo;RL Dominquez;C Ferreccio;EC Lazcano-Ponce;MM Meza-Montenegro;EM Pena;R Pena;P Correa;ME Martinez;WD Chey;M Valdivieso;GL Anderson;GE Goodman;JJ Crowley;LH Baker
Journal / Conference
Journal of the American Medical Association, 309(6):578-586;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID23403682
PMC
PMC3697935
Study Number(s)
S0701

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG trial S0701)

Authors
C Porras;J Nodora;R Sexton;R Ferreccio;S Jimenez;RL Dominguez;MP Cook;GL Anderson;DR Morgan;LH Baker;ER Greenberg;R Herrero
Journal / Conference
Cancer Causes and Control 24(2):209-215;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID23263777
PMC
PMC3645498
Study Number(s)
S0701

Projecting prostate mortality in the PCPT and REDUCE chemoprevention trials

Authors
PF Pinsky;A Black;R Grubb;ED Crawford;G Andriole;IM Thompson;H Parnes
Journal / Conference
Cancer 119(3):593-601;
Year
2013
Research Committee(s)
Cancer Control
PMID
PMID22893105
PMC
PMC3502695
Study Number(s)
SWOG-9217

The impact of initial fludarabine therapy on transformation to richter's syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

Authors
M Solh;KR Rai;BL Peterson;JE Kolitz;F Appelbaum;M Tallman;A Belch;RA Larson;VA Morrison
Journal / Conference
Leukemia & Lymphoma 54(2):252-254
Year
2013
Research Committee(s)
Leukemia
PMID
PMID22897733

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, melphalan (BEAM) compared with 131-iodine tositumomab/BEAM with autologous stem cell transplantation for relapsed diffuse large b-cell lymphoma (DLBCL): results from the Blood and Marrow Transplant Clinical Trials Netword (BMT CTN) 0401 trial

Authors
J Vose;S Carter;L Burns;E Ayala;O Press;C Moskowitz;E Stadtmauer;S Mineshi;R Ambinder;T Fenske;M Horowitz;RI Fisher;M Tomblyn
Journal / Conference
Journal of Clinical Oncology 31(13):1662-1668;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23478060
PMC
PMC3635682

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients < 70 years of age with previously untreated mantle cell lymphoma: SWOG 0213

Authors
S Bernstein;E Epner;J Unger;M LeBlanc;E Cebula;WR Burack;L Rimsza;TP Miller;RI Fisher
Journal / Conference
Annals of Oncology 24(6):1587-1593;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23504948
PMC
PMC3660082
Study Number(s)
S0213

Phase I study evaluating the combination of lapatinib and everolimus in patients with advanced cancers: SWOG study S0528

Authors
S Gadgeel;D Lew;T Synold;P LoRusso;V Chung;S Christensen;D Smith;L Kingsbury;A Hoering;R Kurzrock
Journal / Conference
Cancer Chemotherapy and Pharmacology 72(5):1089-1096;
Year
2013
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID24057042
PMC
PMC4072025
Study Number(s)
S0528

Induction chemoradiotherapy followed by consolidation cytotoxic therapy for superior sulcus (Pancoast tumors) non-small cell lung cancer: a SWOG-coordinated feasibility phase II intergroup trial (S0220)

Authors
K Kernstine;J Moon;M Kraut;K Pisters;J Sonett;V Rusch;CR Thomas;T Waddell;J Jett;A Lyss;S Keller;D Gandara
Journal / Conference
Annals of Thoracic Surgery 94(6):2172-2175; Society of Thoracic Surgeons 2013 Annual Meeting (Jan 26-30, 2013, Los Angeles, CA), oral presenation;
Year
2013
Research Committee(s)
Lung
Study Number(s)
S0220

Autologous transplant as consolidation for aggressive non-hodgkin's lymphoma

Authors
P Stiff;J Unger;J Cook;L Constine;S Couban;D Stewart;T Shea;P Porcu;J Winter;BS Kahl;T Miller;R Tubbs;D Marcellus;J Friedberg;K Barton;G Mills;M Leblanc;L Rimsza;S Forman;RI Fisher
Journal / Conference
New England Journal of Medicine, 369(18):1681-1690;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID24171516
PMC
PMC3985418
Study Number(s)
S9704

A phase III study of of gemtuzumab ozogamicin during induction and post-consolidation therapy in younger patients with acute myeloid leukemia (AML): SWOG intergroup trial S0106

Authors
S Petersdorf;K Kopecky;M Slovak;C Willman;T Nevill;J Brandwein;RA Larson;H Erba;P Stiff;RK Stuart;M Tallman;L Stenke;F Appelbaum
Journal / Conference
Blood 121(24):4854-4860;
Year
2013
Research Committee(s)
Leukemia
PMID
PMID23591789
PMC
PMC3682338
Study Number(s)
S0106